Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
PREGABALIN (PREGABALIN) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
PREGABALIN
ANDA
Get alerts
PREGABALIN | A091025 | ACTAVIS ELIZABETH LLC
8 strengths
0 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
Price Trends
Medicare D
DMF
Label
Products
Products (8)
Sort:
Name
↑
Applicant
Strength
Approval
#001 — 25MG
0 patents
0 exclusivities
▴
CAPSULE;ORAL | Approved: Jul 9, 2020
No patent or exclusivity listings for this strength.
#002 — 50MG
0 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jul 9, 2020
#003 — 75MG
0 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jul 9, 2020
#004 — 100MG
0 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jul 9, 2020
#005 — 150MG
0 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jul 9, 2020
#006 — 200MG
0 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jul 9, 2020
#007 — 225MG
0 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jul 9, 2020
#008 — 300MG
0 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jul 9, 2020